6
Oct
2026
Peter Greven Nederland C.V.
Exhibitor at CPHI Milan 2026 stand 1B104, Excipients&Fine Chemicals
About Us
Categories
-
Country/Region:Netherlands
-
On CPHI since:2019
-
Certificates:3
-
Employees:250 - 499
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 1B104, Excipients&Fine Chemicals
Products Featured at CPHI Milan 2026
-
Product LIGAMED MF-2-V-MB
LIGAMED MF-2-V-MB is our most widely used excipient for the production of tablets and capsules. Its high specific surface area and fine particles offer a high releasing speed during tablet pressing and consistent physical performance of the tablets such as hardness and dissolution profiles. Due to the exce... -
Product LIGAMED CPR-2-V-MB
Some pharmaceutical formulations include vegetable based Calcium Stearate instead of Magnesium Stearate. Our LIGAMED CPR-2-V-MB is a perfect choice encompassing all core LIGAMED® pharmaceutical excipient principles. LIGAMED CPR-2-V is also used as a water repellent agent in the production of effervescent t... -
Product PALMSTAR AL PHARMA-MB
PALMSTAR AL PHARMA-MB is one of our Aluminium Stearates with the best gelling performance capabilities. It is very suitable as an emulsion stabilizer and viscosity increasing agent for creams and ointments. Additionally, pharmaceutical applications use it as an anti-caking agent or suspending agent. PALMST... -
Product LIGAMED MF-2-V-SG
LIGAMED MF-2-V-SG is the RSPO Segregated certified alternative product for LIGAMED MF-2-V-MB. It offers the same positive properties as the standards product but is produced with RSPO Segregated certified fatty acid.
-
Product LIGAMED MF-2-V-BI-MB
LIGAMED MF-2-K-BI-MB is the RSPO Mass Balance certified alternative product for LIGAMED MF-2-V-BI. It offers the same positive properties as the standards product but is produced with RSPO Mass Balance certified fatty acid.
Peter Greven Nederland C.V. Resources (1)
-
Video What is the Impact of the Excipient Manufacturer in the Nitrosamine World?
What is the impact of the excipient manufacturer in the nitrosamine world? During the presentation, the focus will be held on magnesium stearate. Magnesium stearate is used as an excipient in the pharmaceutical industry. For some years, the FDA and EMA have been looking at the nitrosamine content in pharmaceuticals. Based on the realization that some drugs have shown a too high content of nitrosamines, a guideline for the risk assessment of nitrosamines was established by the FDA, in which all ingredients should be assessed for the presence of nitrosamines. IPEC has also introduced a nitrosamine risk assessment questionnaire for excipient manufacturers.




